DK2875121T3 - NON-PATHOGUE F18-E. COLI STRAINS AND USE THEREOF - Google Patents

NON-PATHOGUE F18-E. COLI STRAINS AND USE THEREOF Download PDF

Info

Publication number
DK2875121T3
DK2875121T3 DK13819873.4T DK13819873T DK2875121T3 DK 2875121 T3 DK2875121 T3 DK 2875121T3 DK 13819873 T DK13819873 T DK 13819873T DK 2875121 T3 DK2875121 T3 DK 2875121T3
Authority
DK
Denmark
Prior art keywords
strain
coli
pathogenic
animals
animal
Prior art date
Application number
DK13819873.4T
Other languages
Danish (da)
English (en)
Inventor
John Morris Fairbrother
Éric Nadeau
Clarisse Desautels
Original Assignee
Prevtec Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevtec Microbia Inc filed Critical Prevtec Microbia Inc
Application granted granted Critical
Publication of DK2875121T3 publication Critical patent/DK2875121T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK13819873.4T 2012-07-20 2013-07-18 NON-PATHOGUE F18-E. COLI STRAINS AND USE THEREOF DK2875121T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (1)

Publication Number Publication Date
DK2875121T3 true DK2875121T3 (en) 2018-04-16

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13819873.4T DK2875121T3 (en) 2012-07-20 2013-07-18 NON-PATHOGUE F18-E. COLI STRAINS AND USE THEREOF

Country Status (17)

Country Link
US (3) US9453195B2 (https=)
EP (1) EP2875121B1 (https=)
JP (1) JP6278960B2 (https=)
KR (1) KR102171028B1 (https=)
CN (1) CN104736695B (https=)
BR (1) BR112015001175B1 (https=)
CA (1) CA2879155C (https=)
DK (1) DK2875121T3 (https=)
ES (1) ES2663019T3 (https=)
HU (1) HUE036545T2 (https=)
MX (1) MX363057B (https=)
PH (1) PH12015500091A1 (https=)
PL (1) PL2875121T3 (https=)
PT (1) PT2875121T (https=)
RS (1) RS57056B1 (https=)
RU (1) RU2670882C9 (https=)
WO (1) WO2014012172A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104736695B (zh) 2012-07-20 2017-05-24 普瑞特克微生物有限责任公司 非致病性f18大肠杆菌菌株及其用途
RU2722036C2 (ru) * 2015-02-11 2020-05-26 Превтек Майкробиа Инк. Усовершенствованная сухая матрица для встраивания жизнеспособных escherichia coli, способ ее получения и ее использования
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
EP3468382A4 (en) * 2016-06-14 2020-01-22 Prevtec Microbia Inc ANIMAL FEED PELLETS WITH FEED ADDITIVE, METHOD FOR THE PRODUCTION AND USE THEREOF
US20200113950A1 (en) * 2017-06-30 2020-04-16 The Rockefeller University Human microbiota derived N-acyl amides for the treatment of human disease
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
EP1100950A4 (en) * 1998-07-30 2002-10-16 Wisconsin Alumni Res Found GASTROINTESTINAL BACTERIAL ANTIBODY PLANTS
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
AU2100402A (en) 2000-11-30 2002-06-11 Bio Balance Corp Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
WO2004033646A2 (en) 2002-10-04 2004-04-22 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
HUE024565T2 (hu) * 2004-02-03 2016-02-29 Prevtec Microbia Inc Élõ baktériumok alkalmazása növekedésserkentésre állatokban
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
CN104736695B (zh) 2012-07-20 2017-05-24 普瑞特克微生物有限责任公司 非致病性f18大肠杆菌菌株及其用途

Also Published As

Publication number Publication date
RS57056B1 (sr) 2018-05-31
US20160361369A1 (en) 2016-12-15
RU2015105738A (ru) 2016-09-10
EP2875121B1 (en) 2018-01-03
PT2875121T (pt) 2018-03-14
WO2014012172A1 (en) 2014-01-23
US20150152377A1 (en) 2015-06-04
US9775867B2 (en) 2017-10-03
CN104736695A (zh) 2015-06-24
EP2875121A4 (en) 2016-01-13
ES2663019T3 (es) 2018-04-10
CA2879155A1 (en) 2014-01-23
BR112015001175B1 (pt) 2022-03-03
JP6278960B2 (ja) 2018-02-14
KR102171028B1 (ko) 2020-10-28
CA2879155C (en) 2024-04-30
KR20150036698A (ko) 2015-04-07
EP2875121A1 (en) 2015-05-27
US10258654B2 (en) 2019-04-16
PH12015500091B1 (en) 2015-03-02
RU2670882C9 (ru) 2018-12-11
HUE036545T2 (hu) 2018-07-30
HK1209780A1 (en) 2016-04-08
MX2015000905A (es) 2015-09-28
US9453195B2 (en) 2016-09-27
RU2670882C2 (ru) 2018-10-25
US20180008651A1 (en) 2018-01-11
MX363057B (es) 2019-03-06
JP2015525566A (ja) 2015-09-07
CN104736695B (zh) 2017-05-24
PL2875121T3 (pl) 2018-06-29
BR112015001175A2 (pt) 2017-06-27
PH12015500091A1 (en) 2015-03-02

Similar Documents

Publication Publication Date Title
DK2875121T3 (en) NON-PATHOGUE F18-E. COLI STRAINS AND USE THEREOF
Wu et al. Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli
Haesebrouck et al. Efficacy of vaccines against bacterial diseases in swine: what can we expect?
Hermans et al. Campylobacter control in poultry by current intervention measures ineffective: urgent need for intensified fundamental research
US8343751B2 (en) Use of live bacteria for growth promotion in animals
US20250034218A1 (en) Antimicrobial peptides
Unterweger et al. Treatment with probiotic bacteria does not diminish the impact of a Cystoisospora suis challenge in suckling piglets
Unterweger et al. Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
Herich et al. Effect of preventive application of Enterococcus faecium EF55 on intestinal mucosa during salmonellosis in chickens
CN112638409A (zh) 组合疫苗
HK1209780B (en) Non-pathogenic f18 e. coli strain and use thereof
KR102100503B1 (ko) 개선된 고스트 장관독소형 대장균를 유효성분으로 포함하는 돼지 대장균증의 예방 또는 치료용 백신 조성물
CN118556072A (zh) 抗菌肽
El Dimerdash et al. Studies on the effect of some probiotics in Rabbits
Nhi et al. SWINE COLIBACILLOSIS IN PIG
Pereira et al. Fatores de virulência da Escherichia coli associados à importância da vacinação nos suínos
Cox Identification of the receptor for F18+ E. coli: new perspectives towards development of a prophylactic treatment against F18+ E. coli infections in pigs